Tagged with

Ministry of Health Czech Republic Dr. Heger, you were appointed as the Czech Minister of Health in July of 2010. What challenges did you see for the Czech healthcare system, and what has been your overall vision for reform? I believe that we continue to face the same difficulties today that we have faced for…

Currently, what are the main priorities and goals of ISPAT related to the Healthcare and Pharmaceuticals sector, and what are the overall strategies designed to achieve these objectives? As an agency we aim to attract high quality FDI to Turkey. With “high quality” we mean investments that would enable technology…

Poland and Turkey present many similarities, in terms of market size and frequency of reforms for instance, but also a lot of differences, as the generic penetration is much lower here. As a manager, what specific skills developed during your tenure in Poland are you applying in this market? In…

What were the first challenges you have faced as the new General Manager of Celgene turkey? In all humility, I have to say that even though it is always challenging to work in a new country, new culture, and new position, our company values have really helped me adapt to…

Can you describe the current investment climate in Turkey for pharma companies? Turkey’s economic and political situation are very important factors to consider for foreign investors. Over the last three years especially, the economy has been growing steadily; in addition, there is today a relatively more political stability compared to…

At Reckitt Benckiser, you have gradually taken positions of increasing responsibility over the last decade in Marketing. What would you highlight as the main specificities of Turkish market compared to your previous experiences, in terms of the commercial strategy pharma and healthcare companies need to adopt? Turkey is a highly…

Mr. Ediz Günsel, could you introduce yourself to our readers ? Yes; I have been with the firm over twenty years, including 5 years with PwC London. In my twenty years, I have focused on two major industries, pharmaceuticals and energy. Because of our industry focus globally and locally, I…

Ferring Pharmaceuticals Turkey The company entered the Turkish market in 2005, and made important product launches in 2008. You have been General Manager of Ferring Turkey over those last 7 years. Can you come back on the positive and negative experiences for you during this time? I believe that Ferring’s start in 2005…

Cegedim Czech Republic Mr. Krýza, Mr. Nádvorník, between the two of you, you have over 21 years of experience at Cegedim, and have watched this company grow significantly through a series of mergers. What has been the historical development of the Czech affiliate? Tomáš Nádvorník: Cegedim was established in the Czech Republic in…

Cegedim Czech Republic Mr. Krýza, Mr. Nádvorník, between the two of you, you have over 21 years of experience at Cegedim, and have watched this company grow significantly through a series of mergers. What has been the historical development of the Czech affiliate? Tomáš Nádvorník: Cegedim was established in the Czech Republic in…

DAIICHI SANKYO TURKEY Would you like to come back for our readers on the main milestones in Daiichi Sankyo’s development over the past few years in Turkey and how it positions itself in this market? Daiichi Sankyo entered the Turkish market four years ago. At the time, little did we know that we…

Ipsen Czech Republic Ms. Hauser, you represent what is perhaps the last major generation of medical doctors in this country that left the medical field to join the pharmaceutical business. What do you find are the greatest differences between the Czech pharma industry you joined in 1993 with Wellcome, and the industry you…